Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/1996
10/29/1996CA1338681C Method for the determination of the activity of serine proteases or serine protease inhibitors
10/24/1996WO1996033412A1 Compositions, methods and apparatus for ultrafast electroseparation analysis
10/24/1996WO1996033288A1 Gene marker associated with swine proliferacy
10/24/1996WO1996033287A1 Juvenile glaucoma detection process
10/24/1996WO1996033286A1 Assay and reagents for detecting inhibitors of ubiquitin-dependent degradation of cell cycle regulatory proteins
10/24/1996WO1996033285A1 Efflux pump inhibitors
10/24/1996WO1996033284A2 Nucleic acid sequencing
10/24/1996WO1996033278A1 New cathepsin c homolog
10/24/1996WO1996033274A1 Helicobacter pylori cagi region
10/24/1996WO1996033271A2 Genetic markers for breast and ovarian cancer
10/24/1996WO1996033268A1 Apopain
10/24/1996WO1996033207A1 End-complementary polymerase reaction
10/24/1996WO1996033205A1 Dna sequencing by parallel oligonucleotide extensions
10/24/1996WO1996032959A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996WO1996032936A1 Inhibition of glutathione transferase by haloenol lactones
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996WO1996028549A3 Hyaluronan receptor expressed in human umbilical vein endothelial cells
10/24/1996WO1996027128A3 Hiv determinants required for in vivo replication
10/24/1996WO1996017953A3 Genetic basis of factor xiii activity
10/24/1996WO1996014432A3 Medium for detecting target microbes in a sample
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218679A1 Apopain
10/24/1996CA2218599A1 Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
10/24/1996CA2217865A1 Efflux pump inhibitors
10/24/1996CA2217010A1 New cathepsin c homolog
10/23/1996EP0738779A2 Direct cloning of PCR amplified nucleic acids
10/23/1996EP0738733A2 Method for isolating nucleic acids
10/23/1996EP0738394A1 Ubiquitin conjugating enzymes
10/23/1996EP0738392A1 Apparatus for separation, concentration and detection of target molecules in a liquid sample
10/23/1996EP0738332A1 Indicator cell line for detecting rna viruses and method therefor
10/23/1996EP0738331A1 A NUCLEIC ACID DIAGNOSTIC METHOD USING RIBOPROBES, RNAse DIGESTION, AND MOLECULAR WEIGHT EXCLUSION CHROMATOGRAPHY
10/23/1996EP0738330A1 Methods for using resonance energy transfer-based assay of hiv-1 envelope clycoprotein-mediated membrane fusion, and kits for practicing same
10/23/1996EP0738323A1 Thrombopoietin
10/23/1996EP0738321A1 Association of kinesin with sensitivity to chemotherapeutic drugs
10/23/1996EP0673437A4 Hepadnavirus polymerase having rna-dependent dna priming and reverse transcriptase activities and methods of measuring these activities.
10/23/1996EP0646124A4 A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor.
10/23/1996EP0641351B1 Enzymatic analysis using substrates that yield fluorescent precipitates
10/23/1996EP0430991B1 Reagent for use in ld-1 assay
10/23/1996EP0379559B1 Method and reagents for detecting nucleic acid sequences
10/23/1996CN1134172A Protocadherin proteins and their uses
10/23/1996CN1134156A Synthesizing and screening molecular diversity
10/23/1996CN1134154A Metal complexes with charged linker
10/23/1996CN1133888A Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
10/22/1996US5567869 Method and apparatus for quantitation of relevant blood parameters
10/22/1996US5567811 Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
10/22/1996US5567809 Methods and reagents for HLA DRbeta DNA typing
10/22/1996US5567807 Using an anionic exchange resin
10/22/1996US5567626 Method of detecting biological materials using a polyvinyllidene fluoride membrane
10/22/1996US5567617 Apparatus for heating a fluid-carrying compartment of reaction cuvette
10/22/1996US5567605 Assay for D-allose using a NAD cofactor coupled D-allose dehydrogenase
10/22/1996US5567603 HIV-3 retrovirus and its use
10/22/1996US5567598 Microbial monitoring device
10/22/1996US5567597 Hydrolytic enzyme inhibitors/inactivators and methods for using same
10/22/1996US5567596 Rapid assay of activators and inhibitors of clotting
10/22/1996US5567592 Identifying compounds useful for increasing bioavailability of drug in mammal
10/22/1996US5567588 Forming nucleic acid-target complexes; partitioning increased affinity nucleic acids; amplification
10/22/1996US5567587 Method for detecting, the presence and amount of prokaryotic organisms using specific rRNA subsequences as probes
10/22/1996US5567586 Obtaining sample of solid tumor and detecting presence of all-1 gene rearrangement or mutation
10/22/1996US5567585 Without oxidation or reduction pre-treatment
10/22/1996US5567583 Methods for reducing non-specific priming in DNA detection
10/22/1996US5567582 Dna sequences
10/22/1996US5567581 Method and kit for enzymatically determining the pH of a specimen
10/22/1996US5567290 Fluid samples, polyvinyl chloride membranes, barriers and permeability to hydrogen peroxide, oxalate and oxalic acid and impermeable to paracetamol
10/22/1996CA1338663C Biosynthetic osteogenic proteins and osteogenic devices containing them
10/17/1996WO1996032643A1 Method of detecting biological materials using a polyvinylidene fluoride membrane
10/17/1996WO1996032640A1 Sensitive immunoassays utilizing antibody conjugates with replicable dna templates
10/17/1996WO1996032504A2 Solid phase sequencing of biopolymers
10/17/1996WO1996032503A1 Reverse two-hybrid systems
10/17/1996WO1996032502A1 Reagent specific for apolipoprotein-j polymorphisms and uses thereof
10/17/1996WO1996032501A1 Process for reducing the formation of artefacts during transcription of rebonucleic acids to deoxynucleic acids
10/17/1996WO1996032500A1 Method for amplifying specific nucleic acid sequences
10/17/1996WO1996032499A1 Method of quantitative determination of reversibly acting inhibitors of oxidoreductases
10/17/1996WO1996032497A1 Biological reagent spheres
10/17/1996WO1996032496A2 Covalently linked oligonucleotide minor groove binder conjugates
10/17/1996WO1996032481A1 New chemokine expressed in eosinophils
10/17/1996WO1996032475A2 Methods for preparing dna-binding proteins
10/17/1996WO1996032405A1 Nucleic acid probes for detecting e. coli o157:h7
10/17/1996WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996WO1996032007A1 Transgenic tomato plants containing a fusarium resitance gene
10/17/1996WO1996027797A3 Zap 70 inhibitors and methods for treatment of zap 70 signal transduction disorders
10/17/1996WO1996023066A3 Prostaglandin receptor, dp
10/17/1996WO1996022375A3 Procedures and materials for conferring disease resistance in plants
10/17/1996WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
10/17/1996WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
10/17/1996WO1996017951A3 Identification of genes responsible for in vivo survival of microorganisms
10/17/1996WO1996008246A3 Inducers of gamma globin gene expression and screening assays therefor
10/17/1996WO1994017191A3 Protein fusions for the translocation of apo-proteins into the periplasmic space
10/17/1996DE19514004A1 Verfahren zur quantitativen Bestimmung von reversibel wirkenden Inhibitoren der Oxidoreduktasen A method for quantitative determination of reversibly acting inhibitor of oxidoreductases
10/17/1996CA2218188A1 Solid phase sequencing of biopolymers
10/17/1996CA2218026A1 Method for amplifying specific nucleic acid sequences
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2217545A1 Reverse two-hybrid systems
10/17/1996CA2217025A1 New chemokine expressed in eosinophils
10/17/1996CA2216466A1 Sensitive immunoassays utilizing antibody conjugates with replicable dna templates
10/17/1996CA2215141A1 Transgenic tomato plants containing a fusarium resistance gene
10/17/1996CA2192929A1 Method of quantitative determination of reversibly acting inhibitors of oxidoreductases
10/16/1996EP0737496A1 Image displaying game system and management system for place of amusement
10/16/1996EP0737495A1 Image displaying game machine and image display controlling method
10/16/1996EP0737314A1 Novel uses for gal4-receptor constructs
10/16/1996EP0737311A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases